You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temozolomide refractory

Showing 1 - 25 of 9,574
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma Trial in Atlanta (Ex Vivo Expanded Allogeneic ?d T Cells in

Not yet recruiting
  • Neuroblastoma
  • +2 more
  • Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Oct 6, 2022

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

Not yet recruiting
  • Solid Tumor
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Aug 30, 2022

Recurrent Glioblastoma, Refractory Glioblastoma Trial in Hangzhou, Huzhou, Ningbo (Temozolomide, B7-H3 CAR-T)

Recruiting
  • Recurrent Glioblastoma
  • Refractory Glioblastoma
  • Hangzhou, Zhejiang, China
  • +2 more
Dec 25, 2022

Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

Recruiting
  • Ewing Sarcoma
  • +5 more
  • Valhalla, New York
    New York Medical College
Oct 24, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

Active, not recruiting
Has Results
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
Oct 20, 2022

Neuroblastoma Trial in United States (TPI 287, Temozolomide, Irinotecan)

Terminated
Has Results
  • Neuroblastoma
  • TPI 287
  • +2 more
  • Phoenix, Arizona
  • +7 more
Apr 20, 2022

Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)

Completed
  • Solid Tumors
  • Primary Brain Tumors
  • Hartford, Connecticut
  • +13 more
Jan 12, 2023

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Neuroblastoma Trial in Worldwide (Bevacizumab, Temozolomide, Irinotecan)

Active, not recruiting
  • Neuroblastoma
  • Vienna, Austria
  • +9 more
Feb 14, 2022

Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)

Terminated
  • Neuroblastoma Recurrent
  • Naxitamab and GM-CSF in combination with irinotecan and temozolomide
  • Hong Kong, Hong Kong
  • +2 more
Nov 8, 2022

Neuroblastoma Trial (Apatinib, Irinotecan, Temozolomide)

Not yet recruiting
  • Neuroblastoma
  • Apatinib, Irinotecan, Temozolomide
  • (no location specified)
Aug 29, 2021

Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)

Not yet recruiting
  • Rhabdomyosarcoma, Child
  • (no location specified)
Jul 13, 2022

Glioblastoma Trial in Korea, Republic of (Temozolomide+Metformin, Temozolomide+Placebo)

Completed
  • Glioblastoma
  • Ilsan, Gyeonggi-Do, Korea, Republic of
  • +11 more
Sep 8, 2021

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Refractory or Recurrent Neuroblastoma in Children Trial (Anlotinib and irinotecan combined with temozolomide)

Not yet recruiting
  • Refractory or Recurrent Neuroblastoma in Children
  • Anlotinib and irinotecan combined with temozolomide
  • (no location specified)
Apr 12, 2021

Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)

Completed
  • Childhood Solid Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Feb 8, 2021